133 related articles for article (PubMed ID: 38113633)
21. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
Zhang LX; Wei ZJ; Xu AM; Zang JH
Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
[TBL] [Abstract][Full Text] [Related]
22. The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study.
Wei S; Shao J; Wang J; Wang G
Ann Transl Med; 2022 Apr; 10(8):457. PubMed ID: 35571436
[TBL] [Abstract][Full Text] [Related]
23. Correlation of serum NLR, PLR and HALP with efficacy of neoadjuvant chemotherapy and prognosis of triple-negative breast cancer.
Lou C; Jin F; Zhao Q; Qi H
Am J Transl Res; 2022; 14(5):3240-3246. PubMed ID: 35702128
[TBL] [Abstract][Full Text] [Related]
24. Prognostic nomogram based on pre-treatment HALP score for patients with advanced non-small cell lung cancer.
Gao S; Huang Q; Wei S; Lv Y; Xie Y; Hao Y
Clinics (Sao Paulo); 2024; 79():100371. PubMed ID: 38735175
[TBL] [Abstract][Full Text] [Related]
25. Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis.
Ni L; Tao J; Xu J; Yuan X; Long Y; Yu N; Wu R; Zhang Y
Arch Gynecol Obstet; 2020 Jan; 301(1):251-261. PubMed ID: 31768743
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
27. A HALP score-based prediction model for survival of patients with the upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Gao X; Lin B; Lin Q; Ye T; Zhou T; Hu M; Zhu H; Lu F; Chen W; Xia P; Zhang F; Yu Z
Bosn J Basic Med Sci; 2022 Apr; 22(2):280-290. PubMed ID: 35020581
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
Onal C; Guler OC; Yildirim BA
Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286
[TBL] [Abstract][Full Text] [Related]
30. The Efficiency of the HALP Score and the Modified HALP Score in Predicting Mortality in Patients with Acute Heart Failure Presenting to the Emergency Department.
Kocaoglu S; Alatli T
J Coll Physicians Surg Pak; 2022 Jun; 32(6):706-711. PubMed ID: 35686400
[TBL] [Abstract][Full Text] [Related]
31. The comparison of inflammatory markers in geriatric and nongeriatric endometrial cancers.
Vural F; Coşkun ADE; Çıtak G; Vural B; Köse G
Cancer Biomark; 2022; 34(4):583-590. PubMed ID: 35431231
[TBL] [Abstract][Full Text] [Related]
32. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
34. Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma.
Romano L; Giuliani A; Tomarelli C; Nervini A; Lazzarin G; Pessia B; Vicentini V; Carlei F; Schietroma M
Med Princ Pract; 2022; 31(6):586-594. PubMed ID: 36323225
[TBL] [Abstract][Full Text] [Related]
35. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
37. Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy.
Shi Y; Shen G; Zeng Y; Ju M; Chen X; He C; Liang L; Ge X; Sun X; Di X
Int Immunopharmacol; 2023 Oct; 123():110773. PubMed ID: 37562292
[TBL] [Abstract][Full Text] [Related]
38. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy.
Kutlu Y; Aydin SG; Bilici A; Oven BB; Olmez OF; Acikgoz O; Hamdard J
Medicine (Baltimore); 2023 Apr; 102(15):e33432. PubMed ID: 37058061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
